An interview with the WHO's chief scientist; South African government sued over vaccine contracts

Taking stock of the drug industry, from the lab to the medicine chest  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by       STAT+: The WHO's chief scientist on Covid-19 vaccines, patent battles, and speeding up access in Africa By Ed Silverman FABRICE COFFRINI/AFP via Getty Images STAT spoke with WHO chief scientist Soumya Swaminathan about its hub to share the resources needed to make Covid-19 vaccines. Read More STAT+: California officials win an empty victory as they try to salvage a pay-to-delay law By Ed Silverman APStock "This (ruling) might have a limited effect,” Michael Carrier, a Rutgers University School of Law professor. Read More STAT+: Patient advocates sue South African government over access to Covid-19 vaccine contracts By Ed Silverman GUILLAUME SOUVANT/AFP via Getty Images A patient advocacy group in South Africa has filed a lawsuit accusing the government of failing to disclose Covid-19 vaccine contracts Read More Sponsor content by LASH GROUP Flexible eBV solutions simplify patient access to therapy Completing the loop from prescription to patient is an essential function of any eBV solution. Flexible offerings start with a bias for action, then move to specific steps that enable prescribers. Behind-the-scenes, eBV solutions integrate multiple streams of information, while maintaining a seamless user experience. Roadblocks sometimes arise, so systems must be nimble enough to solve for each user’s needs. Download the guide to explore how successful eBV solutions guide prescribers, serving up actionable insights when they need them. STAT+: Pfizer to halt controversial contracting with Dutch hospitals over anti-competitive concerns By Ed Silverman Illustration: Alex Hogan/STAT; Photo: Kim Raff for STAT Pfizer will halt a controversial practice of cutting discounts on Enbrel to Dutch hospitals that started ordering less of the drug. Read More Introducing the STATUS List, the definitive accounting of leaders in the life sciences By STAT The definitive list of authoritative leaders and influencers in health and life science. See the list. Read More Tuesday, February 22, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser